0001054274-11-000001.txt : 20110317 0001054274-11-000001.hdr.sgml : 20110317 20110317115013 ACCESSION NUMBER: 0001054274-11-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110317 DATE AS OF CHANGE: 20110317 EFFECTIVENESS DATE: 20110317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: FL FISCAL YEAR END: 1220 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-156928 FILM NUMBER: 11694286 BUSINESS ADDRESS: STREET 1: 850 THIRD AVENUE STREET 2: SUITE 1801 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 800-518-4879 MAIL ADDRESS: STREET 1: 850 THIRD AVENUE STREET 2: SUITE 1801 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP /CA DATE OF NAME CHANGE: 20000303 D 1 primary_doc.xml X0704 D LIVE 0001054274 Alliqua, Inc. 850 THIRD AVENUE SUITE 1801 NEW YORK NY NEW YORK 10022 (646) 218-1450 FLORIDA HEPALIFE TECHNOLOGIES INC ZETA CORP ZETA CORP /CA Corporation true Richard Rosenblum 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Executive Officer Director President and Director of the Issuer David Stefansky 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Executive Officer Director Chairman of the Issuer Joseph Sierchio 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Joseph M. Leone 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Michael Goldberg 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Nochum Stein 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Kenneth Pearsen 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Jeffrey Sklar 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Director Steven C. Berger 850 Third Avenue Suite 1801 New York NY NEW YORK 10022 Executive Officer Chief Financial Officer of the Issuer Biotechnology $1,000,001 - $5,000,000 06 false 2011-03-02 false true true false 0 Palladium Capital Advisors, LLC 129400 None None 230 Park Avenue Suite 539 New York NY NEW YORK 10169 FL FLORIDA false 1000000 1000000 0 The Issuer issued 6,250,000 shares of common stock and a five year warrant to purchase 6,250,000 shares of common stock to the investor in exchange for aggregate consideration of $1,000,000. false 1 154000 true 0 The Issuer issued 437,500 shares of common stock and a five year warrant to purchase 312,500 shares of common stock to the placement agent as consideration for serving as the placement agent. 0 false Alliqua, Inc. Richard Rosenblum Richard Rosenblum President and Director of the Issuer 2011-03-15